Human Primary Tumors Susceptibility to DNA Methylation in Normal Tissues and GermLine Variants in Methyl-Group Metabolism Genes and Updated Version
暂无分享,去创建一个
J. Herman | M. Fraga | M. Paz | M. Esteller | G. Capellá | M. Sanchez-Cespedes | M. Pollán | M. A. Peinado | Sonia Avila
[1] J. Herman,et al. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours , 2002, The Journal of pathology.
[2] J. Herman,et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. , 2001, Human molecular genetics.
[3] H. Zoghbi,et al. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome , 2001, Brain & development (Tokyo. 1979).
[4] A. Mander,et al. Haplotype Analysis in Population-based Association Studies , 2001 .
[5] L. Aaltonen,et al. Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. , 2001, Cancer research.
[6] Hongbing Shen,et al. Polymorphisms of 5,10‐methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case‐control study , 2001, International journal of cancer.
[7] G. Stouffer,et al. MTHFR 677 C-->T mutation: a predictor of early-onset coronary artery disease risk. , 2001, Thrombosis research.
[8] R. Houlston,et al. Polymorphisms and colorectal tumor risk. , 2001, Gastroenterology.
[9] Keith D Robertson,et al. DNA methylation, methyltransferases, and cancer , 2001, Oncogene.
[10] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[11] H. Blom,et al. Folate, Homocysteine and Neural Tube Defects: An Overview , 2001, Experimental biology and medicine.
[12] J. Herman,et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.
[13] Hongbing Shen,et al. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] G. M. Taylor,et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Rudnicki,et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. , 2001, Human molecular genetics.
[16] C. Davis,et al. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. , 2000, The Journal of nutrition.
[17] W. Schulz,et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma , 2000, The Prostate.
[18] T. Bestor,et al. The DNA methyltransferases of mammals. , 2000, Human molecular genetics.
[19] M. Fraga,et al. Rapid quantification of DNA methylation by high performance capillary electrophoresis , 2000, Electrophoresis.
[20] J. Mason,et al. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] Quanhe Yang,et al. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.
[22] J. Herman,et al. CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.
[23] D. Higgs,et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.
[24] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[25] A. Evans,et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations , 1999, Genetic epidemiology.
[26] W. Willett,et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[27] J. Issa,et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. , 1999, Cardiovascular research.
[28] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[29] F. Gabreëls,et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.
[30] M. Esteller,et al. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. , 1997, Carcinogenesis.
[31] Stephen B. Baylin,et al. Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions inde Novo Methylation* , 1997, The Journal of Biological Chemistry.
[32] Frank Grosveld,et al. Transcription Factor Sp1 Is Essential for Early Embryonic Development but Dispensable for Cell Growth and Differentiation , 1997, Cell.
[33] P. Goyette,et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.
[34] R. Banerjee,et al. Defects in human methionine synthase in cblG patients. , 1996, Human molecular genetics.
[35] M. Tsai,et al. High prevalence of a mutation in the cystathionine beta-synthase gene. , 1996, American journal of human genetics.
[36] E. Rimm,et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.
[37] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Bird,et al. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. , 1994, Genes & development.
[39] Z. Siegfried,et al. Spl elements protect a CpG island from de novo methylation , 1994, Nature.
[40] L. Poirier,et al. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. , 1992, Cancer research.
[41] J. Barrett,et al. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. , 1991, Science.
[42] L. Poirier,et al. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. , 1984, The Biochemical journal.
[43] R. Hoffman,et al. Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Ehrlich. DNA alterations in cancer : genetic and epigenetic changes , 2000 .
[45] F. Grosveld,et al. Transcription Factor Sp 1 Is Essential for Early Embryonic Development but Dispensable for Cell Growth and Differentiation , 1997 .
[46] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.
[47] L. Poirier,et al. Methyl group deficiency in hepatocarcinogenesis. , 1994, Drug metabolism reviews.
[48] J. M. Cunningham,et al. Growth and differentiation control. , 1990, Cancer chemotherapy and biological response modifiers.
[49] H. Shinozuka,et al. Choline deficiency and chemical carcinogenesis. , 1986, Advances in experimental medicine and biology.
[50] J. H. van der Westhuyzen. Methionine metabolism and cancer. , 1985, Nutrition and cancer.